We are live on ! Find out more
NERV icon

Minerva Neurosciences
NERV

70 hedge funds and large institutions have $217M invested in Minerva Neurosciences in 2017 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 34 increasing their positions, 17 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more repeat investments, than reductions

Existing positions increased: 34 | Existing positions reduced: 17

1.64% less ownership

Funds ownership: 10.03% → 8.38% (-1.6%)

15% less funds holding

Funds holding: 82 → 70 (-12)

17% less capital invested

Capital invested by funds: $261M → $217M (-$43.9M)

58% less first-time investments, than exits

New positions opened: 8 | Existing positions closed: 19

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $112K

Holders
70
Holders Change
-12
Holders Change %
-14.63%
% of All Funds
1.75%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
8
Increased
34
Reduced
17
Closed
19
Calls
–
Puts
$112K
Net Calls
-$112K
Net Calls Change
-$837K

Top Buyers

Rank Fund Capital Flow
1
AC
Ascend Capital
California
+$5.6M
2
JP Morgan Chase
JP Morgan Chase
New York
+$2.78M
3
BlackRock
BlackRock
New York
+$1.97M
4
Renaissance Technologies
Renaissance Technologies
New York
+$1.37M
5
Millennium Management
Millennium Management
New York
+$1.37M

Top Sellers

Rank Fund Capital Flow
1
CAM
Cormorant Asset Management
Massachusetts
-$9.96M
2
O
OrbiMed
New York
-$3.05M
3
JGC
J. Goldman & Co
New York
-$2.14M
4
EC
EcoR1 Capital
California
-$1.98M
5
Citigroup
Citigroup
New York
-$1.8M
Name Holding Trade Value Shares
Change 		Change in
Stake
PRCM
76
Pine River Capital Management
Minnesota
– -$443K -6,250 Closed
D.E. Shaw & Co
77
D.E. Shaw & Co
New York
– -$398K -5,616 Closed
Citadel Advisors
78
Citadel Advisors
Florida
– -$354K -4,999 Closed
LCM
79
Laurion Capital Management
New York
– -$326K -4,600 Closed
Tudor Investment Corp
80
Tudor Investment Corp
Connecticut
– -$266K -3,750 Closed
Jacobs Levy Equity Management
81
Jacobs Levy Equity Management
New Jersey
– -$252K -3,563 Closed
MCM
82
Moore Capital Management
New York
– -$221K -3,125 Closed
MLICM
83
Metropolitan Life Insurance Company (MetLife)
New York
– -$170K -2,397 Closed
DTL
84
Dynamic Technology Lab
Singapore
– -$145K -2,044 Closed
JG
85
Jefferies Group
New York
– -$123K -1,731 Closed
BCM
86
BlueCrest Capital Management
Jersey
– -$95K -1,347 Closed
SSA
87
Schonfeld Strategic Advisors
New York
– -$90K -1,266 Closed
TRCT
88
Tower Research Capital (TRC)
New York
– -$52K -735 Closed
Parallax Volatility Advisers
89
Parallax Volatility Advisers
California
– -$48K -682 Closed
1 2 3
4

NERV Hedge Fund Activity: Q3 2017 in Review

70 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Minerva Neurosciences (NERV) for Q3 2017, worth a combined $217M — down 17% from $261M a quarter earlier.

Sellers outnumbered buyers: 19 funds closed out of NERV and 8 opened new positions — a net loss of 11 holders — while 17 trimmed existing stakes and 34 added.

The largest buyer was Ascend Capital, opening a new position worth an estimated $5.6M. The largest seller was Cormorant Asset Management, cutting an estimated $9.96M.

  • 70 institutional investors held Minerva Neurosciences (NERV) as of Q3 2017, down from 82 in Q2 2017.
  • Funds reported $217M of Minerva Neurosciences stock for Q3 2017, down 17% quarter-over-quarter.
  • 8 funds opened new Minerva Neurosciences positions in Q3 2017 and 19 closed out, a net change of -11 holders.
  • The largest Minerva Neurosciences buyer in Q3 2017 was Ascend Capital, an estimated $5.6M added.
  • The largest Minerva Neurosciences seller in Q3 2017 was Cormorant Asset Management, an estimated $9.96M sold.

Based on aggregated 13F filings for Q3 2017.